FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?

摘要

The commentary focuses on the place of both tools (UDT and PDMP) in risk management efforts. The argument is made that relying on a PDMP alone would lead to clinical decisions that may miss a great deal of problematic or aberrant behaviors.